Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder 
Disaster or digital spectacle? The dangers of using floods to create social media content 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 
How to support someone who is grieving: five research-backed strategies 
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Why financial hardship is more likely if you’re disabled or sick 
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
